Supreme Court asks Centre to explain rationale adopted in Covid vaccine pricing
By LE Desk
New Delhi, April 27: The Supreme Court today asked the Union of India (UOI) to explain the basis and rationale adopted with respect to the pricing of Coronavirus vaccines and other necessary items.
Justice D Y Chandrahud also said that the UOI shall also clarify in its affidavit the basis and rationale adopted in regard to the pricing of vaccines, NDTV reported.
“During the national crisis, Supreme Court cannot be a mute spectator. The role of the Supreme Court is complimentary in nature,” the Supreme Court said.
Each of the state governments has to file their respective replies by Thursday by 6 pm in connection with their respective states with regard to their health infrastructure (shortage of oxygen and others), the Supreme Court said and fixed the matter for further hearing to Friday noon.
“The High Courts shall not be restrained in passing any directions,” as they are hearing the cases in their respective states and they know the ground situation better, the Supreme Court said.
The Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at ₹ 600 per dose for state governments and at ₹ 1,200 per dose for private hospitals.
The Serum Institute of India (SII) has announced a price of ₹ 400 per dose for its COVID-19 vaccine, ‘Covishield’, for state governments and ₹ 600 per dose for private hospitals.
Both vaccines are available to the Central government at a rate of ₹ 150 per dose.
Legitquest is a Legal-Tech venture run by a versatile team of tech-savvy attorneys, engineers and designers who aim to make the practice of law simpler for its end users. We have eminent jurist Mr. Ram Jethmalani as our patron
Add a Comment